Detalhe da pesquisa
1.
Novel Benchmark Values for Open Major Anatomic Liver Resection in Non-cirrhotic Patients: A Multicentric Study of 44 International Expert Centers.
Ann Surg
; 278(5): 748-755, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37465950
2.
Synergistic combination of cytotoxic chemotherapy and cyclin-dependent kinase 4/6 inhibitors in biliary tract cancers.
Hepatology
; 75(1): 43-58, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34407567
3.
Conditional Survival Following Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Surface Malignancies: An Analysis from the US HIPEC Collaborative.
Ann Surg Oncol
; 30(3): 1840-1849, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36310315
4.
Validation of the AJCC 8th Edition Staging System for Disseminated Appendiceal Cancer Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Multi-institutional Analysis.
Ann Surg Oncol
; 30(9): 5743-5753, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37294386
5.
FDG-PET Predicts Neoadjuvant Therapy Response and Survival in Borderline Resectable/Locally Advanced Pancreatic Adenocarcinoma.
J Natl Compr Canc Netw
; 20(9): 1023-1032.e3, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36075389
6.
A novel preoperative risk score to optimize patient selection for performing concomitant liver resection with cytoreductive surgery/HIPEC.
J Surg Oncol
; 123(1): 187-195, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33002202
7.
CRS/HIPEC with Major Organ Resection in Peritoneal Mesothelioma Does not Impact Major Complications or Overall Survival: A Retrospective Cohort Study of the US HIPEC Collaborative.
Ann Surg Oncol
; 27(13): 4996-5004, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33073341
8.
Repeat Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Is Not Associated with Prohibitive Complications: Results of a Multiinstitutional Retrospective Study.
Ann Surg Oncol
; 27(13): 4883-4891, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32318945
9.
Implications of Postoperative Complications for Survival After Cytoreductive Surgery and HIPEC: A Multi-Institutional Analysis of the US HIPEC Collaborative.
Ann Surg Oncol
; 27(13): 4980-4995, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32696303
10.
Optimal Surveillance Frequency After CRS/HIPEC for Appendiceal and Colorectal Neoplasms: A Multi-institutional Analysis of the US HIPEC Collaborative.
Ann Surg Oncol
; 27(1): 134-146, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31243668
11.
Predictors of Anastomotic Failure After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Does Technique Matter?
Ann Surg Oncol
; 27(3): 783-792, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31659645
12.
Preoperative Risk Score for Predicting Incomplete Cytoreduction: A 12-Institution Study from the US HIPEC Collaborative.
Ann Surg Oncol
; 27(1): 156-164, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31602579
13.
Predictors of Non-home Discharge after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
J Surg Res
; 255: 475-485, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32622162
14.
Institutional variation in recovery after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: An opportunity for enhanced recovery pathways.
J Surg Oncol
; 122(5): 980-985, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32627199
15.
The impact of HIPEC vs. EPIC for the treatment of mucinous appendiceal carcinoma: a study from the US HIPEC collaborative.
Int J Hyperthermia
; 37(1): 1182-1188, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33040617
16.
Primary Tumor Sidedness is Predictive of Survival in Colon Cancer Patients Treated with Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy: A US HIPEC Collaborative Study.
Ann Surg Oncol
; 26(7): 2234-2240, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-31016486
17.
ASO Visual Abstract: Validation of the AJCC 8th Edition Staging System for Disseminated Appendiceal Cancer Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy-A Multi-institutional Analysis.
Ann Surg Oncol
; 30(9): 5756-5757, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37423927
18.
ASO Visual Abstract: Conditional Survival After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Surface Malignancies: An Analysis from the US HIPEC Collaborative.
Ann Surg Oncol
; 30(3): 1850-1851, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36418799
19.
Combined Antitumor Effect of the Serine Protease Urokinase Inhibitor Upamostat and the Sphingosine Kinase 2 Inhibitor Opaganib on Cholangiocarcinoma Patient-Derived Xenografts.
Cancers (Basel)
; 16(5)2024 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38473407
20.
Therapeutic Efficacy of Temsirolimus in a Patient-derived Model of Metastatic Fibrolamellar Hepatocellular Carcinoma.
In Vivo
; 37(5): 1940-1950, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37652480